Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul E Clavijo

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Head & Neck|April 16, 2024
Heterogeneous characterization of neutrophilic cells in head and neck cancersMagdalena Fay, Paul E Clavijo, Clint T Allen
Cancers|December 23, 2015
Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic ApproachesClint T Allen, Paul E Clavijo, Carter Van Waes, et al.
The Laryngoscope|March 4, 2024
Quantification and Functional Studies of Neutrophilic Cells Identifies Distinct Papilloma PhenotypesKe Bai, Paul E Clavijo, Yvette Robbins, et al.
Cancer Immunology Research|November 9, 2016
Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway BlockadeEllen Moore, Paul E Clavijo, Ruth Davis, et al.
Oncoimmunology|February 1, 2020
ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancerWenda Ye, Sreenivasulu Gunti, Clint T Allen, et al.
Cancer Immunology Research|December 6, 2018
Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and FunctionPaul E Clavijo, Jay Friedman, Yvette Robbins, et al.
Cancer Immunology Research|January 27, 2019
Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic TumorsTadanobu Nagaya, Jay Friedman, Yasuhiro Maruoka, et al.
Molecular Carcinogenesis|November 30, 2018
Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancerRita Das, Jamie Coupar, Paul E Clavijo, et al.
Oncoimmunology|October 25, 2019
Enhancing direct cytotoxicity and response to immune checkpoint blockade following ionizing radiation with Wee1 kinase inhibitionPriya Patel, Lily Sun, Yvette Robbins, et al.
Cancer Research|April 2, 2017
Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γRuth J Davis, Ellen C Moore, Paul E Clavijo, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Head & Neck|April 16, 2024
Heterogeneous characterization of neutrophilic cells in head and neck cancersMagdalena Fay, Paul E Clavijo, Clint T Allen
Cancers|December 23, 2015
Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic ApproachesClint T Allen, Paul E Clavijo, Carter Van Waes, et al.
The Laryngoscope|March 4, 2024
Quantification and Functional Studies of Neutrophilic Cells Identifies Distinct Papilloma PhenotypesKe Bai, Paul E Clavijo, Yvette Robbins, et al.
Cancer Immunology Research|November 9, 2016
Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway BlockadeEllen Moore, Paul E Clavijo, Ruth Davis, et al.
Oncoimmunology|February 1, 2020
ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancerWenda Ye, Sreenivasulu Gunti, Clint T Allen, et al.
Cancer Immunology Research|December 6, 2018
Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and FunctionPaul E Clavijo, Jay Friedman, Yvette Robbins, et al.
Cancer Immunology Research|January 27, 2019
Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic TumorsTadanobu Nagaya, Jay Friedman, Yasuhiro Maruoka, et al.
Molecular Carcinogenesis|November 30, 2018
Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancerRita Das, Jamie Coupar, Paul E Clavijo, et al.
Oncoimmunology|October 25, 2019
Enhancing direct cytotoxicity and response to immune checkpoint blockade following ionizing radiation with Wee1 kinase inhibitionPriya Patel, Lily Sun, Yvette Robbins, et al.
Cancer Research|April 2, 2017
Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γRuth J Davis, Ellen C Moore, Paul E Clavijo, et al.
Pageof 3